Clinical and MRI phenotype of children with MOG antibodies

Multiple Sclerosis

Volumn 22, Issue 2, 2016, Pages 174-184

  Fernandez Carbonell, Cristina ^a   Vargas Lowy, David ^a   Musallam, Alexander ^a   Healy, Brian ^a,b   McLaughlin, Katherine ^c   Wucherpfennig, Kai W ^c   Chitnis, Tanuja ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Acute disseminated encephalomyelitis; demyelinating syndromes; encephalopathy; glycoprotein; magnetic resonance imaging; multiple sclerosis; myelin; myelin oligodendrocyte glycoprotein; neuromyelitis optica; optic neuritis; pediatric multiple sclerosis; serology

Indexed keywords

AQUAPORIN 4 ANTIBODY; GREEN FLUORESCENT PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; MOG PROTEIN, HUMAN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; BRAIN DISEASE; CELL CLONE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FLOW CYTOMETRY; HUMAN; IMAGE ANALYSIS; JURKAT CELL LINE; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PHENOTYPE; RELAPSE; UNITED STATES; ACUTE DISSEMINATED ENCEPHALOMYELITIS; BRAIN; IMMUNOLOGY; MULTIPLE SCLEROSIS; PATHOLOGY; PATHOPHYSIOLOGY; SPINAL CORD; ACUTE BRAIN DISEASE; BRAIN DAMAGE; CEREBROSPINAL FLUID ANALYSIS; DEMOGRAPHY; DEMYELINATION; EVALUATION AND FOLLOW UP; GENOTYPE PHENOTYPE CORRELATION; MIDDLE AGED; PREVALENCE; RADIODIAGNOSIS; SCHOOL CHILD; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; AQUAPORIN 4; AUTOANTIBODIES; BRAIN; CHILD; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; FLOW CYTOMETRY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS OPTICA; OPTIC NEURITIS; PHENOTYPE; SPINAL CORD;

EID: 84957050301     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515587751     Document Type: Article

References (38)

1. Meinl E, Krumbholz M, Hohlfeld R,. B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production and therapeutic modulation. Ann Neurol 2006; 59: 880-892.
2. Popescu BF, Lucchinetti CF,. Pathology of demyelinating diseases. Ann Rev Pathol 2012; 7: 185-217.
3. O'Connor KC, McLaughlin KA, De Jager PL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med 2007; 13: 211-217.
4. Di Pauli F, Mader S, Rostasy K, et al. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin Immunol 2011; 138: 247-254.
5. McLaughlin KA, Chitnis T, Newcombe J, et al. Age-dependent B-cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J Immunol 2009; 183: 4067-4076.
6. Rostasy K, Mader S, Schanda K, et al. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch Neurol 2012; 69: 752-756.
7. Rostasy K, Mader S, Hennes E, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody-negative pediatric neuromyelitis optica. Mult Scler 2013; 19 (8): 1052-1059.
8. Huppke P, Rostasy K, Karenfort M, et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler 2013; 19: 941-946.
9. Mader S, Gredler V, Schanda K, et al. Complement-activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflamm 2011; 8: 184.
10. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-481.
11. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: A comparative study. JAMA Neurol 2014; 71 (3): 276-283.
12. Kitley J, Woodhall M, Waters P, et al. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012; 79: 1273-1277.
13. Krupp LB, Banwell B, Tenembaum S,. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7-12.
14. Krupp LB, Tardieu M, Amato MP, et al. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Mult Scler 2013; 19 (10): 1261-1267.
15. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
16. Gorman MP, Healy BC, Polgar-Turcsanyi M, et al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009; 66: 54-59.
17. Vishwas MS, Healy BC, Pienaar R, et al. Diffusion tensor analysis of pediatric multiple sclerosis and clinically-isolated syndromes. Am J Neuroradiol 2013; 34: 417-423.
18. Gorman MP, Tillema JM, Ciliax AM, et al. Daclizumab use in patients with pediatric multiple sclerosis. Arch Neurol 2012; 69: 78-81.
19. Schwaiger F, Holzmann H,. Package which implements the silvermantest. R Packages, http://www.uni-marburg.de/fb12/stoch/forschung/rpackages/silvermantest-manual.pdf (2013,. accessed day Month year).
20. Silverman BW,. Using kernel density estimates to investigate multimodality. J Royal Statistical Society Series B 1981; 43: 97-99.
21. Mayer MC, Breithaupt C, Reindl M, et al. Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 2013; 191: 3594-3604.
22. Lalive PH, Hausler MG, Maurey H, et al. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler 2011; 17: 297-302.
23. Probstel AK, Dornmair K, Bittner R, et al. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2011; 77: 580-588.
24. Rostasy K, Mader S, Hennes EM, et al. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody-negative pediatric neuromyelitis optica. Mult Scler 2013; 19: 1052-1059.
25. Brilot F, Dale RC, Selter RC, et al. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann Neurol 2009; 66: 833-842.
26. Selter RC, Brilot F, Grummel V, et al. Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases. Neurology 2010; 74: 1711-1715.
27. Lalive PH, Hausler MG, Maurey H, et al. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult Scler 2011; 17: 297-302.
28. Baumann M, Sahin K, Lechner C, et al. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein. J Neurol Neurosurg Psychiatry 2015; 86 (3): 265-272.
29. Banwell B, Kennedy J, Sadovnick D, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology 2009; 72: 232-239.
30. Chitnis T,. Role of puberty in multiple sclerosis risk and course. Clin Immunol 2013; 149: 192-200.
31. Storch MK, Stefferl A, Brehm U, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998; 8: 681-694.
32. Iglesias A, Bauer J, Litzenburger T, et al. T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia 2001; 36: 220-234.
33. Sakuma H, Kohyama K, Park IK, et al. Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats. Brain 2004; 127: 2201-2213.
34. Bettelli E, Baeten D, Jager A, et al. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J Clin Invest 2006; 116: 2393-2402.
35. Krishnamoorthy G, Lassmann H, Wekerle H, et al. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J Clin Investig 2006; 116: 2385-2392.
36. Slavin AJ, Johns TG, Orian JM, et al. Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Development Neurosci 1997; 19: 69-78.
37. Chabas D, Ness J, Belman A, et al. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology 2010; 74: 399-405.
38. Reindl M, Di Pauli F, Rostasy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nature Rev Neurol 2013; 9: 455-461.